Dashboard Tools Market News Investing Ideas Pricing About Us
Sign Up
Log in

Phoenix Biotech Acquisition Corp
NASDAQ:CERO

Watchlist Manager
Phoenix Biotech Acquisition Corp Logo
Phoenix Biotech Acquisition Corp
NASDAQ:CERO
Watchlist
Price: 0.045 USD Market Closed
Market Cap: $949.5k
Write Note Create Alert Ask AI

Phoenix Biotech Acquisition Corp
Investor Relations

Phoenix Biotech Acquisition Corp. operates as a blank check company. The company is headquartered in Philadelphia, Pennsylvania. The company went IPO on 2021-10-06. The firm is formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The firm has not selected any specific business combination target and has not, nor has anyone on its behalf, initiated any substantive discussions, directly or indirectly, with any business combination target. The company intends to focus its search on the healthcare or healthcare related industries in the United States and Europe. The firm has not commenced any operations nor generated any revenues.

Show more
Loading
CERO
S&P 500
1Y 3Y 5Y 10Y 15Y 20Y
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
No Earnings Calls Available

Management

Mr. Christopher B. Ehrlich M.B.A.
CEO & Chair
No Bio Available
Mr. Brian G. Atwood
President & Director
No Bio Available
Dr. Lawrence Corey M.D.
Co-founder & Head of Scientific Advisory Board
No Bio Available
Mr. Andrew Albert Kucharchuk M.B.A.
CFO & Director
No Bio Available
Dr. Kristen Pierce Ph.D.
Chief Development Officer & Director
No Bio Available

Contacts

Address
PENNSYLVANIA
PHILADELPHIA
2001 Market Street, Suite 3400
Contacts
+12157319450.0
sparklesyt

See Also

Summary
CERO intrinsic value, competitors valuation, and company profile.
DCF Valuation
CERO stock valuation using Discount Cash Flow valuation method.
Relative Valuation
CERO stock valuation using valuation multiples.
Wall Street Estimates
CERO price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
CERO stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Back to Top
ALPHA SPREAD
Follow us
Join more than 317,100+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.